{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:18:57Z","timestamp":1787847537409,"version":"build-2784847793"},"reference-count":120,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>This article aims to analyze the relationship between non-obstructive coronary artery disease (NOCAD) and atrial fibrillation (AF), exploring the underlying pathophysiological mechanisms and implications for clinical management. NOCAD and AF are prevalent cardiovascular conditions that often coexist, yet their interrelation is not well understood. NOCAD can lead to ischemic necrosis of cardiomyocytes and their replacement with fibrous tissue, sustaining focal ectopic activity in atrial myocardium. Atrial fibrillation, on the other hand, the most common sustained cardiac arrhythmia, is able to accelerate atherosclerosis and increase oxygen consumption in the myocardium, creating a mismatch between supply and demand, and thus promoting the development or worsening of coronary ischemia. Therefore, NOCAD and AF seem to be a complex interplay with one begets another.<\/jats:p>","DOI":"10.3390\/jcm13164921","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T11:14:41Z","timestamp":1724325281000},"page":"4921","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Spectrum of Non-Obstructive Coronary Artery Disease and Its Relationship with Atrial Fibrillation"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5249-4562","authenticated-orcid":false,"given":"Alexandru-Florinel","family":"Oancea","sequence":"first","affiliation":[{"name":"Department of Internal Medicine I, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Saint Spiridon Emergency Hospital, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Morariu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Saint Spiridon Emergency Hospital, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Buburuz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Saint Spiridon Emergency Hospital, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4131-1019","authenticated-orcid":false,"given":"Ionela-Larisa","family":"Miftode","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"St Parascheva Clinical Hospital of Infectious Diseases, 700116 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu","family":"Miftode","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Saint Spiridon Emergency Hospital, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9438-8565","authenticated-orcid":false,"given":"Ovidiu","family":"Mitu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Saint Spiridon Emergency Hospital, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2696-9915","authenticated-orcid":false,"given":"Alexandru","family":"Jigoranu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Saint Spiridon Emergency Hospital, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana-Elena","family":"Floria","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Saint Spiridon Emergency Hospital, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Timpau","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Saint Spiridon Emergency Hospital, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8357-7048","authenticated-orcid":false,"given":"Andrei","family":"Vata","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"St Parascheva Clinical Hospital of Infectious Diseases, 700116 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Plesca","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"St Parascheva Clinical Hospital of Infectious Diseases, 700116 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Botnariu","sequence":"additional","affiliation":[{"name":"Saint Spiridon Emergency Hospital, 700115 Iasi, Romania"},{"name":"Unit of Diabetes, Nutrition and Metabolic Diseases, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3424-1588","authenticated-orcid":false,"given":"Alexandru","family":"Burlacu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Cardiovascular Disease Institute, 700503 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragos-Viorel","family":"Scripcariu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Regional Institute of Oncology, 700483 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitea","family":"Raluca","sequence":"additional","affiliation":[{"name":"Faculty of Medicine Victor Papilian, University of Lucian Blaga, 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4414-0967","authenticated-orcid":false,"given":"Magdalena","family":"Cuciureanu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7144-2506","authenticated-orcid":false,"given":"Daniela","family":"Tanase","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Saint Spiridon Emergency Hospital, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Costache-Enache","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Saint Spiridon Emergency Hospital, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9465-1503","authenticated-orcid":false,"given":"Mariana","family":"Floria","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Saint Spiridon Emergency Hospital, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/eurheartj\/ehad556","article-title":"New-Onset Atrial Fibrillation and Chronic Coronary Syndrome in the CLARIFY Registry","volume":"45","author":"Gautier","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.atherosclerosis.2019.09.018","article-title":"Risk Stratification of Non-Obstructive Coronary Artery Disease for Guidance of Preventive Medical Therapy","volume":"290","author":"Hwang","year":"2019","journal-title":"Atherosclerosis"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Floria, M., Oancea, A.F., Morariu, P.C., Burlacu, A., Iov, D.E., Chiriac, C.P., Baroi, G.L., Stafie, C.S., Cuciureanu, M., and Scripcariu, V. (2024). An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting \u03921 Selective Antagonist) in Atrial Fibrillation. Pharmaceutics, 16.","DOI":"10.20944\/preprints202402.0975.v1"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Yan, T., Zhu, S., Xie, C., Zhu, M., Weng, F., Wang, C., and Guo, C. (2022). Coronary Artery Disease and Atrial Fibrillation: A Bidirectional Mendelian Randomization Study. J. Cardiovasc. Dev. Dis., 9.","DOI":"10.3390\/jcdd9030069"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"euad328","DOI":"10.1093\/europace\/euad328","article-title":"Coronary Artery Disease in Atrial Fibrillation Ablation: Impact on Arrhythmic Outcomes","volume":"25","author":"Cappello","year":"2023","journal-title":"Europace"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00059-005-2641-5","article-title":"Angina Pectoris with a Normal Coronary Angiogram","volume":"30","author":"Yang","year":"2005","journal-title":"Herz"},{"key":"ref_7","first-page":"e45","article-title":"The Value of Coronary Artery Disease\u2014Reporting and Data System (CAD-RADS) in Outcome Prediction of CAD Patients; a Systematic Review and Meta-Analysis","volume":"11","author":"Ahmadzadeh","year":"2023","journal-title":"Arch. Acad. Emerg. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1002\/ccd.26043","article-title":"Incidence and Characteristics of Patients Presenting with Acute Myocardial Infarction and Non-obstructive Coronary Artery Disease","volume":"86","author":"Najib","year":"2015","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/1358863X15618268","article-title":"Coronary Endothelial Dysfunction in Non-Obstructive Coronary Artery Disease: Risk, Pathogenesis, Diagnosis and Therapy","volume":"21","author":"Shaw","year":"2016","journal-title":"Vasc. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tem.2019.11.001","article-title":"Coronary Microvascular Dysfunction and Estrogen Receptor Signaling","volume":"31","author":"Tunc","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Kissel, C.K., Chen, G., Southern, D.A., Galbraith, P.D., Anderson, T.J., and APPROACH investigators (2018). Impact of Clinical Presentation and Presence of Coronary Sclerosis on Long-Term Outcome of Patients with Non-Obstructive Coronary Artery Disease. BMC Cardiovasc. Disord., 18.","DOI":"10.1186\/s12872-018-0908-z"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1136\/heartjnl-2019-315042","article-title":"Diagnosis of Patients with Angina and Non-Obstructive Coronary Disease in the Catheter Laboratory","volume":"105","author":"Rahman","year":"2019","journal-title":"Heart"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Ono, M., Kawashima, H., Hara, H., Gao, C., Wang, R., Kogame, N., Takahashi, K., Chichareon, P., Modolo, R., and Tomaniak, M. (2020). Advances in IVUS\/OCT and Future Clinical Perspective of Novel Hybrid Catheter System in Coronary Imaging. Front. Cardiovasc. Med., 7.","DOI":"10.3389\/fcvm.2020.00119"},{"key":"ref_14","first-page":"57","article-title":"QCA, IVUS and OCT in Interventional Cardiology in 2011","volume":"1","author":"Reiber","year":"2011","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Tajeddini, F., Nikmaneshi, M.R., Firoozabadi, B., Pakravan, H.A., Ahmadi Tafti, S.H., and Afshin, H. (2020). High Precision Invasive FFR, Low-Cost Invasive iFR, or Non-Invasive CFR?: Optimum Assessment of Coronary Artery Stenosis Based on the Patient-Specific Computational Models. Int. J. Numer. Methods Biomed. Eng., 36.","DOI":"10.1002\/cnm.3382"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ghorbanniahassankiadeh, A., Marks, D.S., and LaDisa, J.F. (2021). Correlation of Computational Instantaneous Wave-Free Ratio with Fractional Flow Reserve for Intermediate Multivessel Coronary Disease. J. Biomech. Eng., 143.","DOI":"10.1115\/1.4049746"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10554-011-9879-1","article-title":"Cardiac magnetic resonance imaging for the diagnosis of patients presenting with chest pain, raised troponin, and unobstructed coronary arteries","volume":"28","author":"Gerbaud","year":"2012","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11897-023-00605-1","article-title":"MINOCA and INOCA: Role in Heart Failure","volume":"20","author":"Almeida","year":"2023","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Woudstra, J., Vink, C.E.M., Schipaanboord, D.J.M., Eringa, E.C., Den Ruijter, H.M., Feenstra, R.G.T., Boerhout, C.K.M., Beijk, M.A.M., De Waard, G.A., and Ong, P. (2023). Meta-Analysis and Systematic Review of Coronary Vasospasm in ANOCA Patients: Prevalence, Clinical Features and Prognosis. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1129159"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2022.11.009","article-title":"Ischemia and No Obstructive Coronary Arteries (INOCA): A Narrative Review","volume":"363","author":"Mehta","year":"2022","journal-title":"Atherosclerosis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1002\/mco2.438","article-title":"Chinese Expert Consensus on the Diagnosis and Treatment of Coronary Microvascular Diseases (2023 Edition)","volume":"4","author":"Chen","year":"2023","journal-title":"MedComm"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e023207","DOI":"10.1161\/JAHA.121.023207","article-title":"Prevalence of Coronary Microvascular Disease and Coronary Vasospasm in Patients with Nonobstructive Coronary Artery Disease: Systematic Review and Meta-Analysis","volume":"11","author":"Mileva","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1177\/0300060519859134","article-title":"Clinical Characteristics and Biomarkers of Coronary Microvascular Dysfunction and Obstructive Coronary Artery Disease","volume":"47","author":"Mayala","year":"2019","journal-title":"J. Int. Med. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1093\/eurheartj\/ehaa503","article-title":"An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group","volume":"41","author":"Kunadian","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2147\/IJNRD.S174018","article-title":"Evaluation of a Protocol for Coronary Artery Disease Investigation in Asymptomatic Elderly Hemodialysis Patients","volume":"11","author":"Gowdak","year":"2018","journal-title":"Int. J. Nephrol. Renov. Dis."},{"key":"ref_26","first-page":"CD004815","article-title":"Routine Invasive Strategies versus Selective Invasive Strategies for Unstable Angina and Non-ST Elevation Myocardial Infarction in the Stent Era","volume":"2016","author":"Fanning","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ehj.2003.11.009","article-title":"Validation of Coronary Flow Reserve Measurements by Thermodilution in Clinical Practice","volume":"25","author":"Barbato","year":"2004","journal-title":"Eur. Heart J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1161\/01.CIR.0000017199.09457.3D","article-title":"Coronary Thermodilution to Assess Flow Reserve: Validation in Humans","volume":"105","author":"Pijls","year":"2002","journal-title":"Circulation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jacc.2015.12.053","article-title":"Coronary Flow Reserve and Microcirculatory Resistance in Patients with Intermediate Coronary Stenosis","volume":"67","author":"Lee","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"798","DOI":"10.4244\/EIJ-D-17-00449","article-title":"Clinical Significance of Concordance or Discordance between Fractional Flow Reserve and Coronary Flow Reserve for Coronary Physiological Indices, Microvascular Resistance, and Prognosis after Elective Percutaneous Coronary Intervention","volume":"14","author":"Usui","year":"2018","journal-title":"EuroIntervention"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.jcin.2018.07.011","article-title":"Doppler Flow Velocity and Thermodilution to Assess Coronary Flow Reserve","volume":"11","author":"Everaars","year":"2018","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Yildiz, M., Ashokprabhu, N., Shewale, A., Pico, M., Henry, T.D., and Quesada, O. (2022). Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA). Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.1032436"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Bryniarski, K., Gasior, P., Legutko, J., Makowicz, D., Kedziora, A., Szolc, P., Bryniarski, L., Kleczynski, P., and Jang, I.-K. (2021). OCT Findings in MINOCA. J. Clin. Med., 10.","DOI":"10.3390\/jcm10132759"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Jigoranu, R.-A., Roca, M., Costache, A.-D., Mitu, O., Oancea, A.-F., Miftode, R.-S., Haba, M.\u0218.C., Botnariu, E.G., Ma\u0219taleru, A., and Gavril, R.-S. (2023). Novel Biomarkers for Atherosclerotic Disease: Advances in Cardiovascular Risk Assessment. Life, 13.","DOI":"10.3390\/life13081639"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.18087\/cardio.2019.9.10269","article-title":"Spontaneous Coronary Artery Dissection","volume":"59","author":"Zhukova","year":"2019","journal-title":"Kardiologiia"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jacc.2020.05.084","article-title":"Spontaneous Coronary Artery Dissection: JACC State-of-the-Art Review","volume":"76","author":"Hayes","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","article-title":"Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases","volume":"78","author":"Montone","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/HCO.0000000000000886","article-title":"Myocardial Infarction with Nonobstructive Coronary Artery Disease (MINOCA): A Review of Pathophysiology and Management","volume":"36","author":"Cheema","year":"2021","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e013361","DOI":"10.1161\/JAHA.119.013361","article-title":"Myocardial Infarction with Nonobstructive Coronary Arteries: A Call for Individualized Treatment","volume":"8","author":"Mukherjee","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.15420\/icr.2021.10","article-title":"What an Interventionalist Needs to Know About MI with Non-Obstructive Coronary Arteries","volume":"16","author":"Sykes","year":"2021","journal-title":"Interv. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.25122\/jml-2018-0067","article-title":"Takotsubo Cardiomyopathy: A Brief Review","volume":"13","author":"Amin","year":"2020","journal-title":"J. Med. Life"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.18087\/cardio.2020.7.n1209","article-title":"Miocarditis in Patients with COVID-19 Confirmed by Immunohistochemical","volume":"60","author":"Kogan","year":"2020","journal-title":"Kardiologiia"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Timpau, A.-S., Miftode, R.-S., Leca, D., Timpau, R., Miftode, I.-L., Petris, A.O., Costache, I.I., Mitu, O., Nicolae, A., and Oancea, A. (2022). A Real Pandora\u2019s Box in Pandemic Times: A Narrative Review on the Acute Cardiac Injury Due to COVID-19. Life, 12.","DOI":"10.3390\/life12071085"},{"key":"ref_44","first-page":"389","article-title":"Characteristics and Management of Patients with Acute Coronary Syndrome and Normal or Non-Significant Coronary Artery Disease: Results from Acute Coronary Syndrome Israeli Survey (ACSIS) 2004-2010","volume":"26","author":"Minha","year":"2014","journal-title":"J. Invasive Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cjco.2020.09.022","article-title":"Use of Preventive Medications in Patients with Nonobstructive Coronary Artery Disease: Analysis of the PROMISE Trial","volume":"3","author":"Turgeon","year":"2021","journal-title":"CJC Open"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2478\/rjc-2022-0027","article-title":"Stem Cell Therapy in Myocardial Infarction: Still Therapeutic Hope?","volume":"32","author":"Oancea","year":"2022","journal-title":"Rom. J. Cardiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"100302","DOI":"10.1016\/j.ahjo.2023.100302","article-title":"INOCA\/ANOCA: Mechanisms and Novel Treatments","volume":"30","author":"Ashokprabhu","year":"2023","journal-title":"Am. Heart J. Plus Cardiol. Res. Pract."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s11886-023-01874-x","article-title":"Contemporary Diagnosis and Management of Patients with MINOCA","volume":"25","author":"Parwani","year":"2023","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pcad.2023.10.006","article-title":"Characteristics of Patients with Recurrent Acute Myocardial Infarction after MINOCA","volume":"81","author":"Ciliberti","year":"2023","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41569-023-00857-3","article-title":"The Bidirectional Association between Atrial Fibrillation and Myocardial Infarction","volume":"20","author":"Frederiksen","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Oancea, A.F., Jigoranu, R.A., Morariu, P.C., Miftode, R.-S., Trandabat, B.A., Iov, D.E., Cojocaru, E., Costache, I.I., Baroi, L.G., and Timofte, D.V. (2023). Atrial Fibrillation and Chronic Coronary Ischemia: A Challenging Vicious Circle. Life, 13.","DOI":"10.3390\/life13061370"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Carrick, R.T., Benson, B.E., Bates, O.R.J., and Spector, P.S. (2021). Competitive Drivers of Atrial Fibrillation: The Interplay Between Focal Drivers and Multiwavelet Reentry. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.633643"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/jce.14029","article-title":"Impact of Coronary Artery Disease and Revascularization on Recurrence of Atrial Fibrillation after Catheter Ablation: Importance of Ischemia in Managing Atrial Fibrillation","volume":"30","author":"Hiraya","year":"2019","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11883-017-0639-0","article-title":"Influence of Inflammation and Atherosclerosis in Atrial Fibrillation","volume":"19","year":"2017","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41569-022-00759-w","article-title":"Inflammatory Signalling in Atrial Cardiomyocytes: A Novel Unifying Principle in Atrial Fibrillation Pathophysiology","volume":"20","author":"Dobrev","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccep.2020.11.002","article-title":"Implications of Inflammation and Fibrosis in Atrial Fibrillation Pathophysiology","volume":"13","author":"Harada","year":"2021","journal-title":"Card. Electrophysiol. Clin."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2015.2","article-title":"Inflammation and the Pathogenesis of Atrial Fibrillation","volume":"12","author":"Hu","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2012.04.063","article-title":"Inflammation in Atrial Fibrillation","volume":"60","author":"Guo","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Pahimi, N., Rasool, A.H.G., Sanip, Z., Bokti, N.A., Yusof, Z., and W. Isa, W.Y.H. (2022). An Evaluation of the Role of Oxidative Stress in Non-Obstructive Coronary Artery Disease. J. Cardiovasc. Dev. Dis., 9.","DOI":"10.3390\/jcdd9020051"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.yjmcc.2013.04.019","article-title":"Oxidative Stress in Atrial Fibrillation: An Emerging Role of NADPH Oxidase","volume":"62","author":"Youn","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12933-017-0604-9","article-title":"Oxidative Stress and Inflammation as Central Mediators of Atrial Fibrillation in Obesity and Diabetes","volume":"16","author":"Karam","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1080\/10715762.2018.1500696","article-title":"Oxidative Stress and Atrial Fibrillation: An Update","volume":"52","author":"Korantzopoulos","year":"2018","journal-title":"Free Radic. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4938287","DOI":"10.1155\/2023\/4938287","article-title":"Oxidative Stress and Pyroptosis in Doxorubicin-Induced Heart Failure and Atrial Fibrillation","volume":"2023","author":"Ping","year":"2023","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.2174\/1381612824666180903144042","article-title":"Mechanisms and Treatments of Oxidative Stress in Atrial Fibrillation","volume":"24","author":"Ren","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e147371","DOI":"10.1172\/jci.insight.147371","article-title":"Attenuating Persistent Sodium Current\u2013Induced Atrial Myopathy and Fibrillation by Preventing Mitochondrial Oxidative Stress","volume":"6","author":"Avula","year":"2021","journal-title":"JCI Insight"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"9656078","DOI":"10.1155\/2016\/9656078","article-title":"Cellular and Molecular Mechanisms of Arrhythmia by Oxidative Stress","volume":"2016","author":"Sovari","year":"2016","journal-title":"Cardiol. Res. Pract."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/eurheartj\/ehs079","article-title":"The Multidimensional Role of Calcium in Atrial Fibrillation Pathophysiology: Mechanistic Insights and Therapeutic Opportunities","volume":"33","author":"Nattel","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Yuan, M., Gong, M., He, J., Xie, B., Zhang, Z., Meng, L., Tse, G., Zhao, Y., Bao, Q., and Zhang, Y. (2022). IP3R1\/GRP75\/VDAC1 Complex Mediates Endoplasmic Reticulum Stress-Mitochondrial Oxidative Stress in Diabetic Atrial Remodeling. Redox Biol., 52.","DOI":"10.1016\/j.redox.2022.102289"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.mayocp.2020.11.005","article-title":"Atrial Fibrillation and Endothelial Dysfunction","volume":"96","author":"Corban","year":"2021","journal-title":"Mayo Clin. Proc."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11936-015-0371-4","article-title":"Mechanisms Underlying AF: Triggers, Rotors, Other?","volume":"17","author":"Krummen","year":"2015","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Carnagarin, R., Kiuchi, M.G., Ho, J.K., Matthews, V.B., and Schlaich, M.P. (2019). Sympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation. Front. Neurosci., 12.","DOI":"10.3389\/fnins.2018.01058"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/ncpcardio1370","article-title":"Structural Remodeling in Atrial Fibrillation","volume":"5","author":"Corradi","year":"2008","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/0002-9149(88)91053-3","article-title":"Prevalence and Significance of Atrial Fibrillation in Coronary Artery Disease (CASS Registry)","volume":"61","author":"Cameron","year":"1988","journal-title":"Am. J. Cardiol."},{"key":"ref_74","unstructured":"(2024, July 27). Endothelial Dysfunction due to Atrial Fibrillation\u2014Google Academic. Available online: https:\/\/scholar.google.ro\/scholar?hl=ro&as_sdt=0%2C5&q=Endothelial+Dysfunction+Due+to++atrial+fibrillation&btnG=."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e028482","DOI":"10.1161\/JAHA.122.028482","article-title":"Relationship Between Endothelial Dysfunction and the Outcomes after Atrial Fibrillation Ablation","volume":"12","author":"Okawa","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/jce.15277","article-title":"Endothelial Function and Atrial Fibrillation: A Missing Piece of the Puzzle?","volume":"33","author":"Black","year":"2022","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"8423","DOI":"10.18632\/aging.103149","article-title":"Inflammatory Activation and Endothelial Dysfunction Markers in Patients with Permanent Atrial Fibrillation: A Cross-Sectional Study","volume":"12","author":"Maida","year":"2020","journal-title":"Aging"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/hrt.2007.135277","article-title":"Endothelial Dysfunction and Pathophysiological Correlates in Atrial Fibrillation","volume":"95","author":"Guazzi","year":"2009","journal-title":"Heart"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07853890.2019.1711158","article-title":"Endothelial Function in Patients with Atrial Fibrillation","volume":"52","author":"Khan","year":"2020","journal-title":"Ann. Med."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Miftode, R.-S., Costache, I.-I., Constantinescu, D., Mitu, O., Timpau, A.-S., Hancianu, M., Leca, D.-A., Miftode, I.-L., Jigoranu, R.-A., and Oancea, A.-F. (2023). Syndecan-1: From a Promising Novel Cardiac Biomarker to a Surrogate Early Predictor of Kidney and Liver Injury in Patients with Acute Heart Failure. Life, 13.","DOI":"10.3390\/life13040898"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e13477","DOI":"10.1111\/eci.13477","article-title":"Endothelial Dysfunction and Vascular Maladaptation in Atrial Fibrillation","volume":"51","author":"Qin","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijcard.2018.11.091","article-title":"Role of Autonomic Nervous System in Atrial Fibrillation","volume":"287","author":"Linz","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pcad.2005.06.004","article-title":"Interrelationships between the Autonomic Nervous System and Atrial Fibrillation","volume":"48","author":"Olshansky","year":"2005","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijcard.2006.03.090","article-title":"Atrial Fibrillation Is Associated with Increased Neurohumoral Activation and Reduced Exercise Tolerance in Patients with Non-Ischemic Dilated Cardiomyopathy","volume":"118","author":"Parthenakis","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccep.2020.11.012","article-title":"Autonomic Dysfunction and Neurohormonal Disorders in Atrial Fibrillation","volume":"13","author":"Pfenniger","year":"2021","journal-title":"Card. Electrophysiol. Clin."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Aroor, A.R., DeMarco, V.G., Jia, G., Sun, Z., Nistala, R., Meininger, G.A., and Sowers, J.R. (2013). The Role of Tissue Renin-Angiotensin-Aldosterone System in the Development of Endothelial Dysfunction and Arterial Stiffness. Front. Endocrinol., 4.","DOI":"10.3389\/fendo.2013.00161"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1161\/01.CIR.62.5.936","article-title":"The Relevance of Platelet and Fibrin Thromboembolism of the Coronary Microcirculation, with Special Reference to Sudden Cardiac Death","volume":"62","author":"Genton","year":"1980","journal-title":"Circulation"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Kell, D.B., Lip, G.Y., and Pretorius, E. (2024). Fibrinaloid Microclots and Atrial Fibrillation. Biomedicines, 12.","DOI":"10.20944\/preprints202401.1945.v1"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijcard.2018.02.010","article-title":"Coronary Microembolization and Microvascular Dysfunction","volume":"258","author":"Heusch","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Kei, C.Y., Singh, K., Dautov, R.F., Nguyen, T.H., Chirkov, Y.Y., and Horowitz, J.D. (2023). Coronary \u201cMicrovascular Dysfunction\u201d: Evolving Understanding of Pathophysiology, Clinical Implications, and Potential Therapeutics. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241411287"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2014.160","article-title":"Coronary Microvascular Dysfunction: Mechanisms and Functional Assessment","volume":"12","author":"Camici","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.trsl.2020.05.006","article-title":"Microvascular Thrombosis: Experimental and Clinical Implications","volume":"225","author":"Bray","year":"2020","journal-title":"Transl. Res."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Pintea Bentea, G., Berdaoui, B., Samyn, S., Morissens, M., van de Borne, P., and Castro Rodriguez, J. (2023). Particularities of Coronary Physiology in Patients with Atrial Fibrillation: Insights from Combined Pressure and Flow Indices Measurements. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1206743"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/euhj.2001.2894","article-title":"Effect of Acute Atrial Fibrillation on Phasic Coronary Blood Flow Pattern and Flow Reserve in Humans","volume":"23","author":"Kochiadakis","year":"2002","journal-title":"Eur. Heart J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/eurheartj\/ehm246","article-title":"Impaired Myocardial Perfusion and Perfusion Reserve Associated with Increased Coronary Resistance in Persistent Idiopathic Atrial Fibrillation","volume":"28","author":"Range","year":"2007","journal-title":"Eur. Heart J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmpb.2019.04.009","article-title":"Impaired Coronary Blood Flow at Higher Heart Rates during Atrial Fibrillation: Investigation via Multiscale Modelling","volume":"175","author":"Scarsoglio","year":"2019","journal-title":"Comput. Methods Programs Biomed."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00380-020-01759-x","article-title":"Impaired Coronary Flow Reserve Evaluated by Phase-Contrast Cine Magnetic Resonance Imaging in Patients with Atrial Fibrillations","volume":"36","author":"Sugimoto","year":"2021","journal-title":"Heart Vessel."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/CIRCULATIONAHA.114.009716","article-title":"Interaction of Impaired Coronary Flow Reserve and Cardiomyocyte Injury on Adverse Cardiovascular Outcomes in Patients without Overt Coronary Artery Disease","volume":"131","author":"Taqueti","year":"2015","journal-title":"Circulation"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.4244\/EIJ-D-18-00982","article-title":"The Functional Assessment of Patients with Non-Obstructive Coronary Artery Disease: Expert Review from an International Microcirculation Working Group","volume":"14","author":"Widmer","year":"2019","journal-title":"EuroIntervention"},{"key":"ref_100","first-page":"V01210028","article-title":"Chronic coronary syndrome","volume":"183","author":"Pedersen","year":"2021","journal-title":"Ugeskr Laeger"},{"key":"ref_101","first-page":"349","article-title":"Nonobstructive Coronary Artery Disease in Women: Risk Factors and Noninvasive Diagnostic Assessment","volume":"3","author":"Ferdinand","year":"2019","journal-title":"Cardiovasc. Innov. Appl."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e001638","DOI":"10.1136\/openhrt-2021-001638","article-title":"Diagnostic Role of Coronary CT Angiography in Paroxysmal or First Diagnosed Atrial Fibrillation","volume":"8","author":"Saal","year":"2021","journal-title":"Open Heart"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1007\/s11239-021-02588-z","article-title":"Antithrombotic Strategy and Its Relationship with Outcomes in Patients with Atrial Fibrillation and Chronic Coronary Syndrome","volume":"53","author":"Lv","year":"2022","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.cjca.2021.06.011","article-title":"Management of Atrial Fibrillation in 2021: An Updated Comparison of the Current CCS\/CHRS, ESC, and AHA\/ACC\/HRS Guidelines","volume":"37","author":"Cheung","year":"2021","journal-title":"Can. J. Cardiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1136\/heartjnl-2021-319830","article-title":"Adding to the Evidence or to the Confusion: Dual Antithrombotic Therapy in Chronic Coronary Syndrome and Atrial Fibrillation","volume":"107","author":"Kany","year":"2021","journal-title":"Heart"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ahj.2018.03.001","article-title":"An Open-Label, 2 \u00d7 2 Factorial, Randomized Controlled Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Placebo in Patients with Atrial Fibrillation and Acute Coronary Syndrome and\/or Percutaneous Coronary Intervention: Rationale and Design of the AUGUSTUS Trial","volume":"200","author":"Lopes","year":"2018","journal-title":"Am. Heart J."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1540-8159.2011.03245.x","article-title":"Coronary Artery Disease Potentiates Response to Dofetilide for Rhythm Control of Atrial Fibrillation","volume":"35","author":"Manocha","year":"2012","journal-title":"Pacing Clin. Electrophis"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/jce.14335","article-title":"Class 1C Antiarrhythmic Drugs in Atrial Fibrillation and Coronary Artery Disease","volume":"31","author":"Pantlin","year":"2020","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/eurjpc\/zwad356","article-title":"Sodium\u2013Glucose Co-Transporter-2 Inhibitors for the Prevention of Atrial Fibrillation: A Systemic Review and Meta-Analysis","volume":"31","author":"Zhang","year":"2024","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"102742","DOI":"10.1016\/j.cpcardiol.2024.102742","article-title":"Effects of Mineralocorticoid Receptor Antagonists on New-Onset or Recurrent Atrial Fibrillation: A Bayesian and Frequentist Network Meta-Analysis of Randomized Trials","volume":"49","author":"Karakasis","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1093\/eurheartj\/ehu291","article-title":"Catheter Ablation of Atrial Fibrillation: An Update","volume":"35","author":"Haegeli","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"789","DOI":"10.5152\/AnatolJCardiol.2021.03982","article-title":"Prognostic Value of CHA2DS2-VASc Score in Predicting High SYNTAX Score and in-Hospital Mortality for Non-ST Elevation Myocardial Infarction in Patients without Atrial Fibrillation","volume":"25","year":"2021","journal-title":"Anatol. J. Cardiol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Wojszel, Z.B., Ku\u017ama, \u0141., Rogalska, E., Kurasz, A., Dobrzycki, S., Sobkowicz, B., and Tomaszuk-Kazberuk, A. (2022). A Newly Defined CHA2DS2-VA Score for Predicting Obstructive Coronary Artery Disease in Patients with Atrial Fibrillation\u2014A Cross-Sectional Study of Older Persons Referred for Elective Coronary Angiography. J. Clin. Med., 11.","DOI":"10.3390\/jcm11123462"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.amjcard.2018.06.001","article-title":"Previous and New Onset Atrial Fibrillation and Associated Outcomes in Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events)","volume":"122","author":"Worme","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Severino, P., D\u2019Amato, A., Pucci, M., Infusino, F., Adamo, F., Birtolo, L.I., Netti, L., Montefusco, G., Chimenti, C., and Lavalle, C. (2020). Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218118"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/joa3.12473","article-title":"Role of Inflammation in Atrial Fibrillation: A Comprehensive Review of Current Knowledge","volume":"37","author":"Nso","year":"2021","journal-title":"J. Arrhythmia"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"419","DOI":"10.5543\/tkda.2014.84032","article-title":"The Effect of Oxidative Stress Related with Ischemia-Reperfusion Damage on the Pathogenesis of Atrial Fibrillation Developing after Coronary Artery Bypass Graft Surgery","volume":"42","author":"Oktay","year":"2014","journal-title":"Arch. Turk. Soc. Cardiol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e003957","DOI":"10.1161\/JAHA.116.003957","article-title":"Neurohormonal Activation After Atrial Fibrillation Initiation in Patients Eligible for Catheter Ablation: A Randomized Controlled Study","volume":"5","author":"Charitakis","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"ref_119","first-page":"1112","article-title":"Mechanisms and Management of Thrombo-Embolism in Atrial Fibrillation","volume":"7","author":"Violi","year":"2014","journal-title":"J. Atr. Fibrillation"},{"key":"ref_120","first-page":"29","article-title":"The Relationship between Coronary Microvascular Dysfunction, Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction","volume":"11","author":"Ozcan","year":"2021","journal-title":"Am. J. Cardiovasc. Dis."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/16\/4921\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:40:02Z","timestamp":1760110802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/16\/4921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":120,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["jcm13164921"],"URL":"https:\/\/doi.org\/10.3390\/jcm13164921","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,21]]}}}